Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D04AB01	AVOCAINE	G	Lidocaine - 10%	10%	Spray	400,465 L.L
R02A	ANGINOVAG	G	Lidocaine HCl - 100mg/100ml, Hydrocortisone acetate - 60mg/100ml, Tyrothricin - 400mg/100ml, Dequalinium chloride - 100mg/100ml, β-Glycerrhetinic acid - 60mg/100ml		Spray	651,764 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L
R06AX13	APOTHECARE LORATADINE	G	Loratadine - 10mg	10mg	Tablet	430,030 L.L
C10AA02	ATERKEY	G	Lovastatin - 20mg	20mg	Tablet	1,053,573 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	19,022,727 L.L
J01DH02	ARCHIFAR	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	19,022,727 L.L
J01DH02	ARCHIFAR	G	Meropenem - 500mg	500mg	Injectable powder for solution	6,443,725 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	8,454,523 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	12,310,378 L.L
A07EC02	ASACOL	B	Mesalazine - 1g/100ml	1g/100ml	Enema	2,748,158 L.L
A07EC02	ASACOL	B	Mesalazine - 400mg	400mg	Tablet, enteric coated	5,895,437 L.L
A07EC02	ASACOL	B	Mesalazine - 500mg	500mg	Suppository	1,703,992 L.L
A07EC02	ASACOL	B	Mesalazine - 800mg	800mg	Tablet	6,833,439 L.L
A10BD05	ACTOSMET	B	Metformin - 850mg, Pioglitazone - 15mg		Tablet, film coated	3,101,588 L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Ointment	385,683 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Cream	385,683 L.L
D11AX01	ALOPEXY	G	Minoxidil - 2%	2%	Solution	532,162 L.L
D11AX01	ALOPEXY	G	Minoxidil - 20mg/ml	2%	Solution	532,162 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
D11AX01	ALOPEXY	G	Minoxidil - 50mg/ml	5%	Solution	896,343 L.L

...